UK Markets close in 5 hrs 59 mins

Acacia Pharma Group plc (0PNT.L)

LSE - LSE Delayed price. Currency in EUR
Add to watchlist
2.3449+2.3449 (+8.74%)
As of 5:32PM BST. Market open.
Currency in EUR

Valuation measures

Market cap (intra-day) 5N/A
Enterprise value 3198.52M
Trailing P/E N/A
Forward P/E 1N/A
PEG ratio (5-yr expected) 1N/A
Price/sales (ttm)N/A
Price/book (mrq)3.41
Enterprise value/revenue 3940.87
Enterprise value/EBITDA 7-7.12

Trading information

Stock price history

Beta (5Y monthly) 2.02
52-week change 3N/A
S&P500 52-week change 3N/A
52-week high 32.3500
52-week low 32.3449
50-day moving average 3N/A
200-day moving average 3N/A

Share statistics

Avg vol (3-month) 3N/A
Avg vol (10-day) 3N/A
Shares outstanding 5N/A
Implied shares outstanding 6N/A
Float 40.11M
% held by insiders 120.40%
% held by institutions 143.73%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in USD.

Fiscal year

Fiscal year ends 31 Dec 2020
Most-recent quarter (mrq)31 Dec 2020


Profit margin 0.00%
Operating margin (ttm)-14,654.50%

Management effectiveness

Return on assets (ttm)-31.81%
Return on equity (ttm)-103.28%

Income statement

Revenue (ttm)211k
Revenue per share (ttm)0.00
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)182k
EBITDA -27.87M
Net income avi to common (ttm)-33.48M
Diluted EPS (ttm)-0.3780
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)46.69M
Total cash per share (mrq)0.53
Total debt (mrq)36.69M
Total debt/equity (mrq)60.67
Current ratio (mrq)4.55
Book value per share (mrq)0.69

Cash flow statement

Operating cash flow (ttm)-25.36M
Levered free cash flow (ttm)-15.77M